Literature DB >> 22562290

TNF-α, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.

Eva S Kehmeier1, Wolfgang Lepper, Martina Kropp, Christian Heiss, Ulrike Hendgen-Cotta, Jan Balzer, Mirja Neizel, Christian Meyer, Marc W Merx, Pablo E Verde, Christian Ohmann, Gerd Heusch, Malte Kelm, Tienush Rassaf.   

Abstract

AIMS: To characterize the time course of tumor necrosis factor-α (TNF-α) serum levels along with myocardial perfusion and contractile function in patients with ST-segment elevation myocardial infarction (STEMI) and successful primary percutaneous coronary intervention (PCI).
METHODS: Serum levels of TNF-α, interleukin 6 (IL-6), and C-reactive protein (CRP) were measured in 42 patients with STEMI before, one and 6 days after successful PCI. Myocardial perfusion was assessed by contrast-enhanced echocardiography (ceEcho), contractile function by unenhanced two-dimensional (2DE) and real-time three-dimensional echocardiography. In a subset of 18 patients, infarct size was quantified by late gadolinium enhancement cardiovascular magnetic resonance imaging (LGE-CMR) on day six.
RESULTS: TNF-α serum levels were in the upper normal range within the first 12 h from symptom onset and increased continuously until day six, while IL-6 and CRP increased subsequently with a peak on day one after STEMI. Serum TNF-α on day one after PCI correlated with perfusion defects, wall motion abnormalities, and infarct size (ceEcho: r = 0.52, p = 0.005; 2DE: r = 0.56, p = 0.002; LGE-CMR: r = 0.83-0.86; p < 0.0001). Using multiple regression linear analysis, infarct size on day six was predicted by serum TNF-α 1 day after PCI (p = 0.006, adjusted R (2) 0.638).
CONCLUSION: Our data reflect the clinical significance of early TNF-α elevation in patients with STEMI and primary PCI (Controlled Clinical Trials number, NCT00529607).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22562290     DOI: 10.1007/s00392-012-0465-x

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  109 in total

1.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy.

Authors:  David M Leistner; Ulrich Fischer-Rasokat; Jörg Honold; Florian H Seeger; Volker Schächinger; Ralf Lehmann; Hans Martin; Iris Burck; Carmen Urbich; Stefanie Dimmeler; Andreas M Zeiher; Birgit Assmus
Journal:  Clin Res Cardiol       Date:  2011-06-03       Impact factor: 5.460

2.  Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction.

Authors:  Andreas Skyschally; Petra Gres; Simone Hoffmann; Michael Haude; Raimund Erbel; Rainer Schulz; Gerd Heusch
Journal:  Circ Res       Date:  2006-12-14       Impact factor: 17.367

3.  Effects of mild hypothermia on hemodynamics in cardiac arrest survivors and isolated failing human myocardium.

Authors:  Claudius Jacobshagen; Theresa Pelster; Anja Pax; Wiebke Horn; Stephan Schmidt-Schweda; Bernhard W Unsöld; Tim Seidler; Stephan Wagner; Gerd Hasenfuss; Lars S Maier
Journal:  Clin Res Cardiol       Date:  2010-02-04       Impact factor: 5.460

Review 4.  Coronary microembolization.

Authors:  Andreas Skyschally; Kkirsten Leineweber; Petra Gres; Michael Haude; Raimund Erbel; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2006-09       Impact factor: 17.165

5.  Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial.

Authors:  Uwe Zeymer; Hans-Richard Arntz; Bernd Mark; Stephan Fichtlscherer; Gerald Werner; Ralph Schöller; Ralf Zahn; Frank Diller; Harald Darius; Thorsten Dill; Kurt Huber
Journal:  Clin Res Cardiol       Date:  2011-12-21       Impact factor: 5.460

6.  Comparison of two- and three-dimensional echocardiography with sequential magnetic resonance imaging for evaluating left ventricular volume and ejection fraction over time in patients with healed myocardial infarction.

Authors:  Carly Jenkins; Kristen Bricknell; Jonathan Chan; Lizelle Hanekom; Thomas H Marwick
Journal:  Am J Cardiol       Date:  2006-12-01       Impact factor: 2.778

7.  Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits.

Authors:  S Belosjorow; R Schulz; H Dörge; F U Schade; G Heusch
Journal:  Am J Physiol       Date:  1999-12

8.  Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion.

Authors:  N G Frangogiannis; M L Lindsey; L H Michael; K A Youker; R B Bressler; L H Mendoza; R N Spengler; C W Smith; M L Entman
Journal:  Circulation       Date:  1998-08-18       Impact factor: 29.690

9.  Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.

Authors:  Buddhadeb Dawn; Yiru Guo; Arash Rezazadeh; Ou-Li Wang; Adam B Stein; Greg Hunt; Jai Varma; Yu-Ting Xuan; Wen-Jian Wu; Wei Tan; Xiaoping Zhu; Roberto Bolli
Journal:  J Mol Cell Cardiol       Date:  2004-07       Impact factor: 5.000

10.  A comparison between QLAB and TomTec full volume reconstruction for real time three-dimensional echocardiographic quantification of left ventricular volumes.

Authors:  Osama I I Soliman; Boudewijn J Krenning; Marcel L Geleijnse; Attila Nemes; Robert-Jan van Geuns; Timo Baks; Ashraf M Anwar; Tjebbe W Galema; Wim B Vletter; Folkert J ten Cate
Journal:  Echocardiography       Date:  2007-10       Impact factor: 1.724

View more
  6 in total

Review 1.  Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.

Authors:  Cristina Panico; Gianluigi Condorelli
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

2.  Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging.

Authors:  Boqia Xie; Jiaxin Wang; Xiao-Ying Xi; Xiaojuan Guo; Bi-Xi Chen; Lina Li; Cuncun Hua; Shihua Zhao; Pixiong Su; Mulei Chen; Min-Fu Yang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-05       Impact factor: 10.057

3.  Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold.

Authors:  Jens Wiebe; Helge Möllmann; Astrid Most; Oliver Dörr; Kay Weipert; Johannes Rixe; Christoph Liebetrau; Albrecht Elsässer; Stephan Achenbach; Christian Hamm; Holger Nef
Journal:  Clin Res Cardiol       Date:  2013-10-18       Impact factor: 5.460

4.  Reverse-D-4F Increases the Number of Endothelial Progenitor Cells and Improves Endothelial Progenitor Cell Dysfunctions in High Fat Diet Mice.

Authors:  Yang Nana; Jiao Peng; Zhang Jianlin; Zhang Xiangjian; Yao Shutong; Zhan Enxin; Li Bin; Zong Chuanlong; Tian Hua; Si Yanhong; Du Yunsai; Qin Shucun; Wang Hui
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

5.  Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stress.

Authors:  Marie Tomandlova; Jiri Jarkovsky; Josef Tomandl; Lenka Kubkova; Petr Kala; Simona Littnerova; Jana Gottwaldova; Petr Kubena; Eva Ganovska; Martin Poloczek; Jindrich Spinar; Christian Mueller; Alexandre Mebazaa; Monika Pavkova Goldbergova; Jiri Parenica
Journal:  Dis Markers       Date:  2015-04-01       Impact factor: 3.434

Review 6.  Apoptosis in ischemic heart disease.

Authors:  Elena Teringova; Petr Tousek
Journal:  J Transl Med       Date:  2017-05-01       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.